RelB is a key player for both κB-dependent transcription and demethylation in B cells

Immunobiology

Volumn 198, Issue 1-3, 1997, Pages 24-34

  Kistler, Barbara ^b   Baumann, Bernd ^b   Bergman, Yehudit ^a   Wirth, Thomas ^b  

^a HEBREW UNIVERSITY   (Israel)

^b UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ARTICLE; B LYMPHOCYTE; DEMETHYLATION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; PLASMACYTOMA; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

EID: 0031465280     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0171-2985(97)80024-1     Document Type: Article

References (36)

1. SCHRECK, R., B. KISTLER, and T. WIRTH. 1997. The NF-κB/Rel system of transcriptional activators. In: Transcription Factors in Eukaryotes. (PAPAVASSILIOU, A. G., Eds.), Vol., R. G. Landes Company, Austin, Texas.
2. BALDWIN Jr., A. S. 1996. The NF-κB and IκB proteins: new discoveries and insights. Annu. Rev. Immunol. 14: 649-681.
3. BAEUERLE, P. A., and D. BALTIMORE. 1988. Activation of DNA-binding activity in an apparently cytoplasmic precursor of the NF-κB transcription factor. Cell 53: 211-217.
4. BAEUERLE, P. A., and D. BALTIMORE. 1988. IκB: a specific inhibitor of the NF-κB transcription factor. Science 242: 540-546.
5. ZABEL, U., and P. A. BAEUERLE. 1990. Purified human IκB can rapidly dissociate the complex of the NF-κB transcription factor with its cognate DNA. Cell 61: 255-265.
6. ZABEL, U., T. HENKEL, M. DOS SANTOS SILVA, and P. A. BAEUERLE. 1993. Nuclear uptake control of NF-κB by MAD-3, an IκB protein present in the nucleus. EMBO J. 12: 201-211.
7. BROWN, K., S. GERSTBERGER, L. CARLSON, G. FRANZOSO, and U. SIEBENLIST. 1995. Control of IκB-α proteolysis by site-specific, signal-induced phosphorylation. Science 267: 1485-1488.
8. BROCKMAN, J., D. SCHERER, T. MCKINSEY, S. HALL, X. QI, W. LEE, and D. BALLARD. 1995. Coupling of a signal response domain in IκB-α to multiple pathways for NF-κB activation. Mol. Cell. Biol. 15: 2809-2918.
9. TRAENCKNER, E. B., and P. A. BAEUERLE. 1995. Appearance of apparently ubiquitin-conjugated IκB-α during its phosphorylation-induced degradation in intact cells. J. Cell. Sci. Suppl. 19: 79-84.
10. WHITESIDE, S. T., M. K. ERNST, O. LEBAIL, C. LAURENT-WINTER, N. RICE, and A. ISRAEL. 1995. N- and C-terminal sequences control degradation of MAD3/IκB-α in response to inducers of NF-κB activity. Mol. Cell. Biol. 15: 5339-5345.
11. SUN, S., J. ELWOOD, and W. GREENE. 1996. Both amino- and carboyl-terminal sequences within IκBa regulate its inducible degradation. Mol. Cell. Biol. 16: 1058-1065.
12. BAEUERLE, P. A., and T. HENKEL. 1994. Function and activation of NF-κB in the immune system. Annu. Rev. Immunol. 12: 141-179.
13. LERNBECHER, T., U. MÜLLER, and T. WIRTH. 1993. Distinct NF-κB/Rel transcription factors are responsible for tissue-specific and inducible gene activation. Nature 365: 767-770.
14. LENARDO, M., J. W. PIERCE, and D. BALTIMORE. 1987. Protein-binding sites in Ig gene enhancers determine transcriptional activity and inducibility. Science 236: 1573-1577.
15. PIERCE, J. W, M. LENARDO, and D. BALTIMORE. 1988. Oligonucleotide that binds nuclear factor NF-κB acts as a lymphoid-specific and inducible enhancer element. Proc. Natl. Acad. Sci. USA 85: 1482-1486.
16. WIRTH, T., and D. BALTIMORE. 1988. Nuclear factor NF-κB can interact functionally with its cognate binding site to provide lymphoid-specific promoter function. EMBO J. 7: 3109-3113.
17. SCHERER, D. C., J. A. BROCKMAN, H. H. BENDALL, G. M. ZHANG, D. W. BALLARD, and E. M. OLTZ. 1996. Corepression of RelA and c-Rel inhibits immunoglobulin κ gene transcription and rearrangement in precursor B lymphocytes. Immunity 5: 563-574.
18. WEIH, F., D. CARRASCO, and R. BRAVO. 1994. Constitutive and inducible Rel/NF-κB activities in mouse thymus and spleen. Oncogene 9: 3289-3297.
19. LERNBECHER, T., B. KISTLER, and T. WIRTH. 1994. Two distinct mechanisms contribute to the constitutive activation of RelB in lymphoid cells. EMBO J. 13: 4060-4069.
20. BLACKWELL, K. T., and F. W. ALT. 1988. Immunoglobulin genes. In: Molecular Immunology. (HAMES, B. D., and GLOVER, D. M., Eds.), Vol., pp. 1-60, IRL Press, Oxford.
21. TAKEDA, S. Y.-R. ZOU, H. BLUETHMANN, D. KITAMURA, U. MULLER, and K. RAJEWSKY. 1993. Deletion of the immunoglobulin κ chain intron enhancer abolishes κ chain gene rearrangement in cis but not λ chain gene rearrangement in trans. EMBO J. 12: 2329-2336.
22. SERWE, M., and F. SABLITZKY. 1993. V(D)J recombination in B cells is impaired but not blocked by targeted deletion of the immunoglobulin heavy chain intron enhancer. The EMBO J. 12: 2321-2327.
23. H locus. The EMBO J. 12: 4635-4645.
24. LICHTENSTEIN, M., G. KEINI, H. CEDAR, and Y. BERGMAN. 1994. B cell-specific demethylation: a novel role for the intronic κ chain enhancer sequence. Cell 76: 913-923.
25. KIRILLOV, A., B. KISTLER, R. MOSTOSLAVSKY, H. CEDAR, T. WIRTH, and Y. BERGMAN. 1996. A role for nuclear NF-κB in B-cell-specific demethylation of the Igκ locus. Nature Genetics 13: 435-441.
26. BERGMAN, Y., D. RICE, R. GROSSCHEDL, and D. BALTIMORE. 1984. Two regulatory elements for immunoglobulin κ light chain gene expression. Proc. Natl. Acad. Sci. USA 81: 7041-7045.
27. ATCHISON, M. L., and R. P. PERRY. 1987. The role of the κ enhancer and its binding factor NF-κB in the developmental regulation of κ gene transcription. Cell 48: 121-128.
28. SCHRECK R., P. RIEBER, and P. A. BAEUERLE. 1991. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κB transcription factor and HIV-1. EMBO J. 10: 2247-2258.
29. SCHRECK, R., K. ALBERMANN, and P. A. BAEUERLE. 1992. Nuclear factor κB: An oxidative stress-responsive transcription factor of eukaryotic cells. Free Rad. Res. Comms. 17: 221-237.
30. SCHRECK, R., B. MEIER, D. N. MAENNEL, W. DROEGE, and P. A. BAEUERLE. 1992. Dithiocarbamates as potent inhibitors of nuclear factor κB activation in intact cells. J. Exp. Med. 175: 1181-1194.
31. 2 and antioxidants have opposite effects on activation of NF-κB and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor. EMBO J. 12: 2005-2015.
32. NEUMANN, M., G. WOHLLEBEN, S. CHUVPILO, B. KISTLER, T. WIRTH, E. SERFLING, and A. SCHIMPL. 1996. CD40, but not lipopolysaccharide and anti-IgM stimulation of primary lymphocytes, leads to a persistent nuclear accumulation of RelB. J. Immunol. 157: 4862-4869.
33. WEIH, F., D. CARRASCO, S. K. DURHAM, D. S. BARTON, C. A. RIZZO, R.-P. RYSECK, S. A. LIRA, and R. BRAVO. 1995. Multiorgan Inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-κB/Rel family. Cell 80: 331-340.
34. BURKLY, L., C. HESSION, L. OGATA, C. REILLY, L. A. MARCONI, D. OLSON, R. TIZARD, R. CATE, and D. LO. 1995. Expression of relB is required for the development of thymic medulla and dendritic cells. Nature 373: 531-536.
35. SNAPPER, C. M., F. R. ROSAS, P. ZELAZOWSKI, M. A. MOORMAN, M. R. KEHRY, R. BRAVO, and F. WEIH. 1996. B cells lacking RelB are defective in proliferative responses, but undergo normal B cell maturation to Ig secretion and Ig class switching. J. Exp. Med. 184: 1537-1541.
36. PFISTERER, P., A. ANNWEILER, C. ULLMER, L. CORCORAN, and L. WIRTH. 1994. Differential transcactivation potential of Oct1 and Oct2 is determined by additional B cell-specific activities. EMBO J. 13: 1654-1663.